pramipexole sold brand mirapex among others medication used treat parkinsons disease pd restless legs syndrome parkinsons disease may used alone together taken pramipexole dopamine agonist nonergoline pramipexole related dopamine agonist medications ropinirole induce impulsivecompulsive spectrum compulsive gambling punding hypersexuality overeating even people without prior history also reported detrimental side effects related impulsecontrol disorders resulting offlabel use pramipexole dopamine agonists treating clinical incidence severity impulsecontrol disorders taking drug depression fully understood drug approved treatment depression first major studies efficacy treating anhedonic depression conducted anecdotal reports abrupt severe personality changes related impulsivity loss selfcontrol minority patients regardless condition treated although incidence side effects yet fully pramipexole approved medical use united states use pregnancy breastfeeding unclear available generic commonly prescribed medication united states two million pramipexole used treatment parkinsons disease pd restless legs syndrome use pregnancy breastfeeding unclear metaanalysis found pramipexole effective ropinirole treatment occasionally prescribed offlabel depression effectiveness antidepressant may product strong partial agonistic activity preferential occupation dopamine receptors low doses see table well drug shown desensitize inhibitory autoreceptors postsynaptic receptors leading increase dopamine serotonin levels prefrontal chronic administration pramipexole may also result desensitization autoreceptors leading reduced dopamine transporter trials shown mixed results pramipexole also used treatment rem sleep behaviour disorder licensed use disorder observational studies suggest may reduce frequency intensity rem sleep behaviour disorder symptoms randomised controlled trials performed evidence role disorder common side effects pramipexole may activity profile pramipexole various sites characterized follows pramipexole used clinically see receptor binding profile made popular tool compound preclinical research example pramipexole used combination antagonists discover role receptor function rodent models tasks neuropsychiatric note appears pramipexole addition effects dopamine receptors may also affect mitochondrial function via mechanism remains less understood pharmacological approach separate dopaminergic nondopaminergic eg mitochondrial effects pramipexole study effects rstereoisomer pramipexole much lower affinity dopamine receptors compared sisomer side side effects parkinsons disease neurodegenerative disease affecting substantia nigra component basal ganglia substantia nigra high quantity dopaminergic neurons nerve cells release neurotransmitter known dopamine dopamine released may activate dopamine receptors striatum another component basal ganglia neurons substantia nigra deteriorate parkinsons disease striatum longer properly receives dopamine signals result basal ganglia longer regulate body movement effectively motor function becomes impaired acting agonist dopamine receptors pramipexole may directly stimulate underfunctioning dopamine receptors striatum thereby restoring dopamine signals needed proper functioning basal ganglia pramipexole increase growth hormone indirectly inhibition somatostatin brand names include mirapex mirapex er mirapexin sifrol glepark oprymeacitation needed pramipexole evaluated treatment sexual dysfunction experienced users selective serotonin reuptake inhibitor ssri pramipexole shown effects pilot studies placebocontrolled proof concept study bipolar also investigated treatment clinical depression derivatives pramipexole include httpsenwikipediaorgwikipramipexole